Reimbursement Scheme Elvanse®
Elvanse's medicine page has been updated. In the menu 'who can submit a claim' you can now read more about the declaration process of this Reimbursement…
Claiming for multiple family members
TBR Nederland has added a new function to your account for submitting claims for several people within the same family. This way you no longer have to create…
We are here to help you use TerugBetaalRegelling optimally. On this page, you will find all relevant information, whether you want to open an account, read about our app or learn…
Launch of TerugBetaalRegeling Broxil®
The health insurer does not fully reimburse Broxil® 125 mg / 5 mL, powder for oral suspension. The producer of this medicine has therefore asked TBR…
Launch of TerugBetaalRegeling Acecort® en Fludrace®
The health insurer does not fully reimburse Acecort® 1mg and Fludrace® 62.5mcg. The producer of this medicine has therefore asked TBR…
Termination TerugBetaalRegeling Xarelto®
Xarelto® is fully reimbursement from the 1st of January 2020. For this reason the co-payment is ended. Expenses from before the 1st of January 2020 can…
Termination TerugBetaalRegeling Invega®
Invega® is fully reimbursement from the 1st of December 2019. For this reason the co-payment is ended. Expenses from before the 1st of December 2019 can…
Specified overview health insurer
To consider and process an invoice of a GVS medicine, we need a specified overview of your healthcare costs issued by your health insurer. Each health insurer’s…
